Catch-up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase 3 Clinical Trial.

被引：0

作者：

De Benedetti, Fabrizio ^{[1
]}

Ruperto, Nicolino ^{[2
]}

Espada, Graciela ^{[2
]}

Gerloni, Valeria ^{[2
]}

Flato, Berit ^{[2
]}

Horneff, Gerd ^{[3
]}

Myones, Barry L. ^{[4
]}

Onel, Karen ^{[4
]}

Frane, James ^{[5
]}

Kenwright, Andrew ^{[6
]}

Lipman, Terri H. ^{[7
]}

Bharucha, Kamal N. ^{[5
]}

Martini, Alberto ^{[2
]}

Lovell, D. J. ^{[8
]}

机构：

[1] IRCCS Osped Pediat Bambino Gesu, Rome, Italy

[2] Paediat Rheumatol Int Trials Org PRINTO, Genoa, Italy

[3] Ctr Pediat Rheumatol, St Augustin, Germany

[4] Pediat Rheumatol Collaborat Study Grp PRSCG, Cincinnati, OH USA

[5] Genentech Inc, San Francisco, CA 94080 USA

[6] Roche, Welwyn Garden City, Herts, England

[7] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA

[8] Cincinnati Childrens Hosp, Cincinnati, OH USA

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

760

引用

页码：S327 / S327

页数：1

共 50 条

[1] CATCH-UP GROWTH DURING TOCILIZUMAB THERAPY FOR SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 2-YEAR DATA FROM A PHASE 3 CLINICAL TRIAL
De Benedetti, F.
Ruperto, N.
Espada, G.
Gerloni, V.
Flato, B.
Horneff, G.
Myones, B.
Onel, K.
Frane, J.
Wang, J.
Lipman, T.
Bharucha, K.
Martini, A.
Lovell, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 729 - 730
[2] CATCH-UP GROWTH DURING TOCILIZUMAB THERAPY FOR SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 2-YEAR DATA FROM A PHASE 3 CLINICAL TRIAL
De Benedetti, F.
Ruperto, N.
Espada, G.
Gerloni, V.
Flato, B.
Horneff, G.
Myones, B. L.
Onel, K.
Frane, J.
Wang, J.
Lipman, T. H.
Bharucha, K. N.
Martini, A.
[J]. RHEUMATOLOGY, 2014, 53 : 1 - 1
[3] CATCH-UP GROWTH DURING TOCILIZUMAB THERAPY FOR SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: TENDER 2-YEAR DATA
De Benedetti, Fabrizio
Ruperto, Nicolino
Espada, Graciela
Gerloni, Valeria
Flato, Berit
Horneff, Gerd
Myones, Barry L.
Onel, Karen
Frane, James
Kenwright, Andrew
Lipman, Terri H.
Bharucha, Kamal N.
Martini, Alberto
Lovell, Daniel J.
[J]. RHEUMATOLOGY, 2013, 52 : 34 - 34
[4] Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis Results From a Phase III Trial
De Benedetti, Fabrizio
Brunner, Hermine
Ruperto, Nicolino
Schneider, Rayfel
Xavier, Ricardo
Allen, Roger
Brown, Diane E.
Chaitow, Jeffrey
Pardeo, Manuela
Espada, Graciela
Gerloni, Valeria
Myones, Barry L.
Frane, James W.
Wang, Jianmei
Lipman, Terri H.
Bharucha, Kamal N.
Martini, Alberto
Lovell, Daniel
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67 (03) : 840 - 848
[5] Growth during Tocilizumab Therapy for Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data from a Phase 3 Clinical Trial.
Bharucha, Kamal N.
Brunner, Hermine I.
Ruperto, Nicola
Cabral, David A.
Gedalia, Abraham
Gerloni, Valeria
Jorgensen, Christian
Ramanan, Athimalaipet
Lovell, Daniel
Martini, Alberto
Frane, James
Wells, Chris
De Benedetti, Fabrizio, Sr.
[J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S117 - S117
[6] Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial
Bharucha, Kamal N.
Brunner, Hermine I.
Calvo Penades, Inmaculada
Nikishina, Irina
Rubio-Perez, Nadina
Oliveira, Sheila
Kobusinska, Katarzyna
Schmeling, Heinrike
Sztajnbok, Flavio
Weller-Heinemann, Frank
Zholobova, Elena
Zulian, Francesco
Allen, Roger
Chaitow, Jeffrey
Frane, James
Wells, Chris
Ruperto, Nicolino
De Benedetti, Fabrizio
[J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (08) : 1173 - 1179
[7] Efficacy and Safety of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial
De Benedetti, Fabrizio
Brunner, Hermine
Ruperto, Nicolino
Kenwright, Andrew
Devlin, Clare
Calvo, Inmaculada
Cuttica, Ruben
Ravelli, Angelo
Schneider, Rayfel
Eleftheriou, Despina
Wouters, Carine H.
Xavier, Ricardo
Zemel, Lawrence S.
Baildam, Eileen M.
Burgos-Vargas, Ruben
Dolezalova, Pavla
Garay, Stella Maris
Joos, Rik
Grom, Alexei
Wulffraat, Nico
Zuber, Zbigniew
Zulian, Francesco
Martini, Alberto
Lovell, Daniel
[J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4047 - 4047
[8] EFFICACY AND SAFETY OF TOCILIZUMAB (TCZ) IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 2-YEAR DATA FROM TENDER, A PHASE 3 CLINICAL TRIAL
De Benedetti, F.
Brunner, H.
Ruperto, N.
Kenwright, A.
Devlin, C.
Calvo, I.
Cuttica, R.
Ravelli, A.
Schneider, R.
Eleftheriou, D.
Wouters, C.
Xavier, R.
Zemel, L.
Baildam, E.
Burgos-Vargas, R.
Dolezalova, P.
Garay, S. M.
Joos, R.
Grom, A.
Wulffraat, N.
Zuber, Z.
Zulian, F.
Lovell, D.
Martini, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 425 - 425
[9] GROWTH DURING TOCILIZUMAB THERAPY IN PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS: 2-YEAR DATA FROM THE PHASE III CHERISH TRIAL
Ramanan, Athimalaipet
Bharucha, Kamal N.
Brunner, Hermine I.
Ruperto, Nicola
Cabral, David A.
Gedalia, Abraham
Gerloni, Valeria
Jorgensen, Christian
Lovell, Daniel J.
Martini, Alberto
Frane, Jim
Wells, Chris
De Benedetti, Fabrizio
[J]. RHEUMATOLOGY, 2015, 54 : 157 - 158
[10] Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial.
Brunner, Hermine
Ruperto, Nicolino
Zuber, Zbigniew
Keane, Caroline
Harari, Olivier
Kenwright, Andrew
Cuttica, Ruben J.
Keltsev, Vladimir
Xavier, Ricardo
Penades, Inmaculada Calvo
Nikishina, Irina
Rubio-Perez, Nadina
Alekseeva, Ekaterina
Chasnyk, Vyacheslav
Chavez, Jose
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Silva, Clovis A.
Silverman, Earl D.
Spindler, Alberto
Lovell, D. J.
Martini, Alberto
De Benedetti, Fabrizio
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S682 - S682

← 1 2 3 4 5 →